Syndax Pharmaceuticals (SNDX) PT Lowered to $31 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Chris Shibutani lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $31.00 (from $33.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
